nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB2—skin epidermis—leprosy	0.0596	0.177	CbGeAlD
Carfilzomib—Disease progression—Thalidomide—leprosy	0.0515	0.105	CcSEcCtD
Carfilzomib—Tumour lysis syndrome—Thalidomide—leprosy	0.0405	0.0825	CcSEcCtD
Carfilzomib—Peripheral sensory neuropathy—Thalidomide—leprosy	0.0394	0.0801	CcSEcCtD
Carfilzomib—PSMB10—testis—leprosy	0.024	0.0713	CbGeAlD
Carfilzomib—PSMB10—nervous system—leprosy	0.0235	0.0699	CbGeAlD
Carfilzomib—Lymphopenia—Thalidomide—leprosy	0.022	0.0448	CcSEcCtD
Carfilzomib—PSMB1—eye—leprosy	0.0218	0.0646	CbGeAlD
Carfilzomib—PSMB2—eye—leprosy	0.0212	0.0631	CbGeAlD
Carfilzomib—PSMB1—skin of body—leprosy	0.0189	0.0562	CbGeAlD
Carfilzomib—PSMB8—tendon—leprosy	0.0187	0.0554	CbGeAlD
Carfilzomib—PSMB2—skin of body—leprosy	0.0185	0.0549	CbGeAlD
Carfilzomib—Hypomagnesaemia—Thalidomide—leprosy	0.0177	0.0361	CcSEcCtD
Carfilzomib—PSMB5—tendon—leprosy	0.0165	0.049	CbGeAlD
Carfilzomib—Hypercalcaemia—Thalidomide—leprosy	0.0162	0.033	CcSEcCtD
Carfilzomib—PSMB8—testis—leprosy	0.0154	0.0459	CbGeAlD
Carfilzomib—Neuritis—Thalidomide—leprosy	0.0151	0.0307	CcSEcCtD
Carfilzomib—PSMB1—tendon—leprosy	0.0144	0.0428	CbGeAlD
Carfilzomib—PSMB2—tendon—leprosy	0.0141	0.0418	CbGeAlD
Carfilzomib—Myocardial ischaemia—Thalidomide—leprosy	0.014	0.0285	CcSEcCtD
Carfilzomib—PSMB5—testis—leprosy	0.0136	0.0406	CbGeAlD
Carfilzomib—Neuropathy peripheral—Dapsone—leprosy	0.0121	0.0245	CcSEcCtD
Carfilzomib—PSMB1—testis—leprosy	0.0119	0.0354	CbGeAlD
Carfilzomib—PSMB1—nervous system—leprosy	0.0117	0.0348	CbGeAlD
Carfilzomib—PSMB2—testis—leprosy	0.0116	0.0346	CbGeAlD
Carfilzomib—PSMB2—nervous system—leprosy	0.0114	0.0339	CbGeAlD
Carfilzomib—Sepsis—Thalidomide—leprosy	0.00976	0.0199	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Thalidomide—leprosy	0.00901	0.0183	CcSEcCtD
Carfilzomib—Renal failure acute—Thalidomide—leprosy	0.00885	0.018	CcSEcCtD
Carfilzomib—Cough—Dapsone—leprosy	0.00838	0.0171	CcSEcCtD
Carfilzomib—Hyponatraemia—Thalidomide—leprosy	0.0082	0.0167	CcSEcCtD
Carfilzomib—Pain in extremity—Thalidomide—leprosy	0.00817	0.0166	CcSEcCtD
Carfilzomib—Cardiac arrest—Thalidomide—leprosy	0.00777	0.0158	CcSEcCtD
Carfilzomib—Blood creatinine increased—Thalidomide—leprosy	0.00765	0.0156	CcSEcCtD
Carfilzomib—Hypokalaemia—Thalidomide—leprosy	0.00743	0.0151	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00736	0.015	CcSEcCtD
Carfilzomib—Insomnia—Dapsone—leprosy	0.00709	0.0144	CcSEcCtD
Carfilzomib—Neutropenia—Thalidomide—leprosy	0.0066	0.0134	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Thalidomide—leprosy	0.00656	0.0134	CcSEcCtD
Carfilzomib—Hyperglycaemia—Thalidomide—leprosy	0.00637	0.013	CcSEcCtD
Carfilzomib—Pneumonia—Thalidomide—leprosy	0.00633	0.0129	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Thalidomide—leprosy	0.0062	0.0126	CcSEcCtD
Carfilzomib—Body temperature increased—Dapsone—leprosy	0.0062	0.0126	CcSEcCtD
Carfilzomib—Renal failure—Thalidomide—leprosy	0.00619	0.0126	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Thalidomide—leprosy	0.00617	0.0126	CcSEcCtD
Carfilzomib—ABCB1—blood vessel—leprosy	0.00609	0.0181	CbGeAlD
Carfilzomib—Hypoaesthesia—Thalidomide—leprosy	0.00562	0.0114	CcSEcCtD
Carfilzomib—Oedema peripheral—Thalidomide—leprosy	0.00557	0.0113	CcSEcCtD
Carfilzomib—Cardiac disorder—Thalidomide—leprosy	0.00524	0.0107	CcSEcCtD
Carfilzomib—Chills—Thalidomide—leprosy	0.00507	0.0103	CcSEcCtD
Carfilzomib—Vomiting—Dapsone—leprosy	0.00499	0.0101	CcSEcCtD
Carfilzomib—Headache—Dapsone—leprosy	0.00491	0.01	CcSEcCtD
Carfilzomib—Back pain—Thalidomide—leprosy	0.00476	0.00968	CcSEcCtD
Carfilzomib—Muscle spasms—Thalidomide—leprosy	0.00473	0.00963	CcSEcCtD
Carfilzomib—Nausea—Dapsone—leprosy	0.00466	0.00948	CcSEcCtD
Carfilzomib—PSMB9—Type II interferon signaling (IFNG)—IFNG—leprosy	0.00459	0.0266	CbGpPWpGaD
Carfilzomib—Anaemia—Thalidomide—leprosy	0.00455	0.00925	CcSEcCtD
Carfilzomib—Leukopenia—Thalidomide—leprosy	0.0044	0.00896	CcSEcCtD
Carfilzomib—Cough—Thalidomide—leprosy	0.00429	0.00874	CcSEcCtD
Carfilzomib—Hypertension—Thalidomide—leprosy	0.00425	0.00864	CcSEcCtD
Carfilzomib—Arthralgia—Thalidomide—leprosy	0.00419	0.00852	CcSEcCtD
Carfilzomib—Infection—Thalidomide—leprosy	0.00399	0.00812	CcSEcCtD
Carfilzomib—Thrombocytopenia—Thalidomide—leprosy	0.00393	0.008	CcSEcCtD
Carfilzomib—Anorexia—Thalidomide—leprosy	0.00383	0.00779	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Thalidomide—leprosy	0.00366	0.00744	CcSEcCtD
Carfilzomib—Insomnia—Thalidomide—leprosy	0.00363	0.00739	CcSEcCtD
Carfilzomib—Dyspnoea—Thalidomide—leprosy	0.00358	0.00728	CcSEcCtD
Carfilzomib—PSMB10—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—leprosy	0.00352	0.0205	CbGpPWpGaD
Carfilzomib—PSMB9—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—leprosy	0.00351	0.0204	CbGpPWpGaD
Carfilzomib—PSMB10—Vpu mediated degradation of CD4—CD4—leprosy	0.0035	0.0203	CbGpPWpGaD
Carfilzomib—Decreased appetite—Thalidomide—leprosy	0.00349	0.0071	CcSEcCtD
Carfilzomib—PSMB9—Vpu mediated degradation of CD4—CD4—leprosy	0.00348	0.0202	CbGpPWpGaD
Carfilzomib—Fatigue—Thalidomide—leprosy	0.00346	0.00704	CcSEcCtD
Carfilzomib—Pain—Thalidomide—leprosy	0.00343	0.00699	CcSEcCtD
Carfilzomib—Constipation—Thalidomide—leprosy	0.00343	0.00699	CcSEcCtD
Carfilzomib—Body temperature increased—Thalidomide—leprosy	0.00317	0.00646	CcSEcCtD
Carfilzomib—PSMB10—Proteasome Degradation—IFNG—leprosy	0.00305	0.0177	CbGpPWpGaD
Carfilzomib—PSMB9—Proteasome Degradation—IFNG—leprosy	0.00303	0.0176	CbGpPWpGaD
Carfilzomib—PSMB10—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00302	0.0176	CbGpPWpGaD
Carfilzomib—PSMB9—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00301	0.0175	CbGpPWpGaD
Carfilzomib—Asthenia—Thalidomide—leprosy	0.00288	0.00586	CcSEcCtD
Carfilzomib—Diarrhoea—Thalidomide—leprosy	0.00275	0.00559	CcSEcCtD
Carfilzomib—PSMB2—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—leprosy	0.00267	0.0155	CbGpPWpGaD
Carfilzomib—PSMB1—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—leprosy	0.00267	0.0155	CbGpPWpGaD
Carfilzomib—PSMB5—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—leprosy	0.00267	0.0155	CbGpPWpGaD
Carfilzomib—Dizziness—Thalidomide—leprosy	0.00265	0.0054	CcSEcCtD
Carfilzomib—PSMB2—Vpu mediated degradation of CD4—CD4—leprosy	0.00265	0.0154	CbGpPWpGaD
Carfilzomib—PSMB5—Vpu mediated degradation of CD4—CD4—leprosy	0.00265	0.0154	CbGpPWpGaD
Carfilzomib—PSMB1—Vpu mediated degradation of CD4—CD4—leprosy	0.00265	0.0154	CbGpPWpGaD
Carfilzomib—PSMB8—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—leprosy	0.00263	0.0153	CbGpPWpGaD
Carfilzomib—PSMB8—Vpu mediated degradation of CD4—CD4—leprosy	0.00261	0.0152	CbGpPWpGaD
Carfilzomib—Vomiting—Thalidomide—leprosy	0.00255	0.0052	CcSEcCtD
Carfilzomib—Headache—Thalidomide—leprosy	0.00251	0.00512	CcSEcCtD
Carfilzomib—Nausea—Thalidomide—leprosy	0.00238	0.00485	CcSEcCtD
Carfilzomib—PSMB5—Proteasome Degradation—IFNG—leprosy	0.00231	0.0134	CbGpPWpGaD
Carfilzomib—PSMB1—Proteasome Degradation—IFNG—leprosy	0.00231	0.0134	CbGpPWpGaD
Carfilzomib—PSMB2—Proteasome Degradation—IFNG—leprosy	0.00231	0.0134	CbGpPWpGaD
Carfilzomib—PSMB5—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00229	0.0133	CbGpPWpGaD
Carfilzomib—PSMB1—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00229	0.0133	CbGpPWpGaD
Carfilzomib—PSMB2—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00229	0.0133	CbGpPWpGaD
Carfilzomib—PSMB8—Proteasome Degradation—IFNG—leprosy	0.00228	0.0132	CbGpPWpGaD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00226	0.0131	CbGpPWpGaD
Carfilzomib—ABCB1—testis—leprosy	0.00178	0.00528	CbGeAlD
Carfilzomib—ABCB1—nervous system—leprosy	0.00174	0.00519	CbGeAlD
Carfilzomib—PSMB10—Host Interactions of HIV factors—CD4—leprosy	0.00167	0.0097	CbGpPWpGaD
Carfilzomib—PSMB9—Host Interactions of HIV factors—CD4—leprosy	0.00166	0.00965	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—RIPK2—leprosy	0.00151	0.00879	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—PARK2—leprosy	0.0015	0.00869	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—PARK2—leprosy	0.00149	0.00865	CbGpPWpGaD
Carfilzomib—PSMB8—Interferon Signaling—HLA-DRB1—leprosy	0.0014	0.00812	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—NOD2—leprosy	0.00137	0.00797	CbGpPWpGaD
Carfilzomib—PSMB5—Host Interactions of HIV factors—CD4—leprosy	0.00127	0.00735	CbGpPWpGaD
Carfilzomib—PSMB1—Host Interactions of HIV factors—CD4—leprosy	0.00127	0.00735	CbGpPWpGaD
Carfilzomib—PSMB2—Host Interactions of HIV factors—CD4—leprosy	0.00127	0.00735	CbGpPWpGaD
Carfilzomib—PSMB8—Host Interactions of HIV factors—CD4—leprosy	0.00125	0.00724	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—PARK2—leprosy	0.00113	0.00658	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—PARK2—leprosy	0.00113	0.00658	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—PARK2—leprosy	0.00113	0.00658	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—PARK2—leprosy	0.00112	0.00649	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—RIPK2—leprosy	0.00109	0.00633	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—RIPK2—leprosy	0.00109	0.0063	CbGpPWpGaD
Carfilzomib—PSMB10—HIV Infection—CD4—leprosy	0.00108	0.0063	CbGpPWpGaD
Carfilzomib—PSMB9—HIV Infection—CD4—leprosy	0.00108	0.00627	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CYLD—leprosy	0.00103	0.00596	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CYLD—leprosy	0.00102	0.00593	CbGpPWpGaD
Carfilzomib—PSMB8—Interferon Signaling—IFNG—leprosy	0.00102	0.00593	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL10—leprosy	0.000952	0.00553	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CD40LG—leprosy	0.000952	0.00553	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—TNF—leprosy	0.000948	0.00551	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—TNF—leprosy	0.000944	0.00548	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000934	0.00542	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—SDHD—leprosy	0.000933	0.00542	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—SDHD—leprosy	0.000929	0.00539	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—PARK2—leprosy	0.000907	0.00527	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—PARK2—leprosy	0.000903	0.00524	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—SLC11A1—leprosy	0.000838	0.00486	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD40LG—leprosy	0.000836	0.00485	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—SLC11A1—leprosy	0.000834	0.00484	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD40LG—leprosy	0.000832	0.00483	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—RIPK2—leprosy	0.000826	0.0048	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—RIPK2—leprosy	0.000826	0.0048	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—RIPK2—leprosy	0.000826	0.0048	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD8A—leprosy	0.000826	0.0048	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD8A—leprosy	0.000823	0.00478	CbGpPWpGaD
Carfilzomib—PSMB1—HIV Infection—CD4—leprosy	0.000822	0.00477	CbGpPWpGaD
Carfilzomib—PSMB5—HIV Infection—CD4—leprosy	0.000822	0.00477	CbGpPWpGaD
Carfilzomib—PSMB2—HIV Infection—CD4—leprosy	0.000822	0.00477	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—RIPK2—leprosy	0.000815	0.00473	CbGpPWpGaD
Carfilzomib—PSMB8—HIV Infection—CD4—leprosy	0.000811	0.00471	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CYLD—leprosy	0.000778	0.00452	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CYLD—leprosy	0.000778	0.00452	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CYLD—leprosy	0.000778	0.00452	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CYLD—leprosy	0.000767	0.00445	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	0.000767	0.00445	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TNF—leprosy	0.000719	0.00417	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TNF—leprosy	0.000719	0.00417	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TNF—leprosy	0.000719	0.00417	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TNF—leprosy	0.000708	0.00411	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—SDHD—leprosy	0.000707	0.00411	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—SDHD—leprosy	0.000707	0.00411	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—SDHD—leprosy	0.000707	0.00411	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—SDHD—leprosy	0.000697	0.00405	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PARK2—leprosy	0.000688	0.00399	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PARK2—leprosy	0.000688	0.00399	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PARK2—leprosy	0.000688	0.00399	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IFNG—leprosy	0.000682	0.00396	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PARK2—leprosy	0.000678	0.00394	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-DRB1—leprosy	0.000673	0.00391	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-DRB1—leprosy	0.00067	0.00389	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—RIPK2—leprosy	0.000661	0.00384	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—TLR2—leprosy	0.000661	0.00384	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—RIPK2—leprosy	0.000658	0.00382	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—TLR2—leprosy	0.000658	0.00382	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SLC11A1—leprosy	0.000635	0.00369	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SLC11A1—leprosy	0.000635	0.00369	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SLC11A1—leprosy	0.000635	0.00369	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD40LG—leprosy	0.000633	0.00368	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD40LG—leprosy	0.000633	0.00368	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD40LG—leprosy	0.000633	0.00368	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD8A—leprosy	0.000626	0.00364	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD8A—leprosy	0.000626	0.00364	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD8A—leprosy	0.000626	0.00364	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SLC11A1—leprosy	0.000626	0.00363	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD40LG—leprosy	0.000625	0.00363	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD8A—leprosy	0.000618	0.00359	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL2—leprosy	0.000606	0.00352	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—NOD2—leprosy	0.0006	0.00348	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—NOD2—leprosy	0.000597	0.00347	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IFNG—leprosy	0.00056	0.00325	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-DRB1—leprosy	0.00051	0.00296	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-DRB1—leprosy	0.00051	0.00296	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-DRB1—leprosy	0.00051	0.00296	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD40LG—leprosy	0.000507	0.00294	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD40LG—leprosy	0.000505	0.00293	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-DRB1—leprosy	0.000503	0.00292	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TLR2—leprosy	0.000501	0.00291	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—RIPK2—leprosy	0.000501	0.00291	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—RIPK2—leprosy	0.000501	0.00291	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD8A—leprosy	0.000501	0.00291	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TLR2—leprosy	0.000501	0.00291	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—RIPK2—leprosy	0.000501	0.00291	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TLR2—leprosy	0.000501	0.00291	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD8A—leprosy	0.000499	0.0029	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL2—leprosy	0.000498	0.00289	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—RIPK2—leprosy	0.000494	0.00287	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TLR2—leprosy	0.000494	0.00287	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD4—leprosy	0.000475	0.00276	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD4—leprosy	0.000472	0.00274	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—NOD2—leprosy	0.000454	0.00264	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—NOD2—leprosy	0.000454	0.00264	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—NOD2—leprosy	0.000454	0.00264	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—NOD2—leprosy	0.000448	0.0026	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RIPK2—leprosy	0.000428	0.00248	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RIPK2—leprosy	0.000426	0.00247	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-DRB1—leprosy	0.000408	0.00237	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-DRB1—leprosy	0.000406	0.00236	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD40LG—leprosy	0.000384	0.00223	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD40LG—leprosy	0.000384	0.00223	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD40LG—leprosy	0.000384	0.00223	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD8A—leprosy	0.00038	0.00221	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD8A—leprosy	0.00038	0.00221	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD8A—leprosy	0.00038	0.00221	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD40LG—leprosy	0.000379	0.0022	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD8A—leprosy	0.000375	0.00218	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—leprosy	0.000362	0.0021	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD4—leprosy	0.00036	0.00209	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD4—leprosy	0.00036	0.00209	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD4—leprosy	0.00036	0.00209	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD4—leprosy	0.000355	0.00206	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000334	0.00194	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RIPK2—leprosy	0.000324	0.00188	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RIPK2—leprosy	0.000324	0.00188	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RIPK2—leprosy	0.000324	0.00188	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RIPK2—leprosy	0.00032	0.00186	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DRB1—leprosy	0.000309	0.0018	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DRB1—leprosy	0.000309	0.0018	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DRB1—leprosy	0.000309	0.0018	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DRB1—leprosy	0.000305	0.00177	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IFNG—leprosy	0.000298	0.00173	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFNG—leprosy	0.000297	0.00172	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—leprosy	0.000288	0.00167	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—leprosy	0.000287	0.00166	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—leprosy	0.000266	0.00154	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL2—leprosy	0.000265	0.00154	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—leprosy	0.000265	0.00154	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2—leprosy	0.000264	0.00153	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—leprosy	0.000226	0.00131	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—leprosy	0.000226	0.00131	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—leprosy	0.000226	0.00131	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—leprosy	0.000223	0.00129	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—leprosy	0.000218	0.00127	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—leprosy	0.000218	0.00127	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—leprosy	0.000218	0.00127	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—leprosy	0.000215	0.00125	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SDHD—leprosy	0.000208	0.00121	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—leprosy	0.000201	0.00117	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—leprosy	0.000201	0.00117	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—leprosy	0.000201	0.00117	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—leprosy	0.000201	0.00117	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—leprosy	0.000201	0.00117	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—leprosy	0.000201	0.00117	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—leprosy	0.000199	0.00115	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—leprosy	0.000198	0.00115	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	0.000179	0.00104	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—leprosy	0.000171	0.000995	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—leprosy	0.00017	0.00099	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—leprosy	0.00013	0.000754	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—leprosy	0.00013	0.000754	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—leprosy	0.00013	0.000754	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—leprosy	0.000128	0.000743	CbGpPWpGaD
